Tapewire

NYSE · USD

USPH

U S PHYSICAL THERAPY INC /NV

Export transactions ↓
Tapewire entity
379
SEC CIK
0000885978
Parsed reports
338

Last 12 months

Inside the activity.

5 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202511
Dec 202500
Jan 202600
Feb 202600
Mar 202604
Apr 202600
May 202600
Jun 202630
Jul 202600
Aug 202600
Sep 202610
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 01, 2026 Filed Oct 3, 2026 00:09 UTC
Davis MyraDirector
GrantCommon Stock 1,210 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-412265 · ownership.xml · nonDerivative · entry 1

Davis Myra · CIK 0002156047 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,210

F1 · balance_after: Includes 1,210 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 303 shares will vest on each of November 20, 2026, and March 6, 2027, and 605 shares will vest on May 20, 2027, subject to the Reporting Person's continued service as a director through each applicable vesting date.

Read SEC document
September 14, 2026 Filed Sep 15, 2026 20:09 UTC
Etta NchachaEVP & Chief Financial Officer
GrantCommon Stock 6,831 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-391910 · ownership.xml · nonDerivative · entry 1

Etta Nchacha · CIK 0001976557 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,831

F1 · balance_after: Includes 6,831 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 427 shares will vest on each of November 20, 2026, March 6, 2027, May 20, 2027, August 20 2027, November 20, 2027, March 6, 2028, May 20, 2028, August 20 2028, November 20, 2028, March 6, 2029, May 20, 2029, August 20 2029, November 20, 2029, March 6, 2030, and May 20, 2030, and 426 shares will vest on August 20, 2030. Vesting is subject to his continued employment with the Company through each of the applicable vesting dates.

Read SEC document
September 11, 2026 Filed Sep 14, 2026 20:17 UTC PurchaseCommon Stock 5.27 $79.00 $416.33
Disclosure

SEC source: 0001193125-26-390608 · ownership.xml · nonDerivative · entry 2

Minan Peter Francis · CIK 0001544647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,217.14

F3 · shares: Represents shares acquired through automatic reinvestment of cash dividends in the Reporting Person's brokerage account.

F2 · balance_after: Includes 1,153 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.

Read SEC document
August 20, 2026 Filed Aug 24, 2026 23:12 UTC
Williams Eric JosephPresident and COO
Tax withholdingCommon Stock 714 $78.00 $55,692.00
Disclosure

SEC source: 0001193125-26-363896 · ownership.xml · nonDerivative · entry 1

Williams Eric Joseph · CIK 0001871391 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,617

F1 · shares: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting.

F2 · balance_after: Includes 24,402 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 2,512 shares will vest on November 20, 2026, 2,520 shares vest on March 6, 2027, 2,200 shares vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 2,204 shares vest on March 6, 2028, 1,694 shares vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,716 shares will vest on March 6, 2029, 936 shares vest on each of May 20, 2029, August 20, 2029 and November 20, 2029, and 960 shares will vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each of the applicable vesting dates.

Read SEC document
August 20, 2026 Filed Aug 24, 2026 23:09 UTC Tax withholdingCommon Stock 40 $78.00 $3,120.00
Disclosure

SEC source: 0001193125-26-363894 · ownership.xml · nonDerivative · entry 1

CURTIS JASON TRAVIS · CIK 0001750716 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,853

F1 · shares: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting.

F2 · balance_after: Includes 3,425 shares of common stock subject to vesting restrictions. The shares were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 171 shares vest on each of November 20, 2026, and March 6, 2027, 1,250 shares vest on May 15, 2027, 171 shares vest on each of May 20, 2027, August 20, 2027, November 20, 2027, March 6, 2028, May 20, 2028, August 20, 2028, November 20, 2028, and March 6, 2029, 178 shares vest on May 20, 2029, 93 shares vest on each of August 20, 2029 and November 20, 2029, and 101 shares vest on March 6, 2030. Vesting is contingent upon the reporting person's continued service with the Company through each applicable vesting date.

Read SEC document
August 20, 2026 Filed Aug 24, 2026 23:07 UTC
Binstein RichardEVP Gen'l Counsel & Secretary
Tax withholdingCommon Stock 450 $78.00 $35,100.00
Disclosure

SEC source: 0001193125-26-363890 · ownership.xml · nonDerivative · entry 1

Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,417

F1 · shares: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting.

F2 · balance_after: Includes 17,330 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 1,870 shares will vest on November 20, 2026, 1,876 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates.

Read SEC document
August 20, 2026 Filed Aug 24, 2026 23:04 UTC Tax withholdingCommon Stock 762 $78.00 $59,436.00
Disclosure

SEC source: 0001193125-26-363888 · ownership.xml · nonDerivative · entry 1

REEVE GRAHAM D. · CIK 0001519948 · COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,554

F1 · shares: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting.

F2 · balance_after: Includes 17,488 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 1,948 shares will vest on November 20, 2026, 1,956 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates.

Read SEC document
June 12, 2026 Filed Sep 14, 2026 20:17 UTC PurchaseCommon Stock 0.87 $66.50 $57.86
Disclosure

SEC source: 0001193125-26-390608 · ownership.xml · nonDerivative · entry 1

Minan Peter Francis · CIK 0001544647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,211.87

F1 · shares: Represents a fractional share acquired through the automatic reinvestment of cash dividends in the Reporting Person's brokerage account. This transaction was inadvertently not reported previously and is being reported on this Form 4.

F2 · balance_after: Includes 1,153 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.

Read SEC document
June 09, 2026 Filed Jun 10, 2026 22:36 UTC PurchaseCommon Stock 288 $61.50 $17,712.00
Disclosure

SEC source: 0001193125-26-266197 · ownership.xml · nonDerivative · entry 2

Minan Peter Francis · CIK 0001544647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,211

F1 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.

Read SEC document
June 08, 2026 Filed Jun 10, 2026 22:36 UTC PurchaseCommon Stock 492 $63.14 $31,064.88
Disclosure

SEC source: 0001193125-26-266197 · ownership.xml · nonDerivative · entry 1

Minan Peter Francis · CIK 0001544647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,923

F1 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.

Read SEC document
May 20, 2026 Filed Jun 22, 2026 21:01 UTC Tax withholdingCommon Stock 40 $62.24 $2,489.60
Disclosure

SEC source: 0001193125-26-277664 · ownership.xml · nonDerivative · entry 1

CURTIS JASON TRAVIS · CIK 0001750716 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,893

F1 · shares: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting.

F2 · balance_after: Includes 3,596 shares of common stock subject to vesting restrictions. The shares were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 171 shares vest on each of August 20, 2026, November 20, 2026, and March 6, 2027; 1,250 shares vest on May 15, 2027; 171 shares vest on each of May 20, 2027, August 20, 2027, November 20, 2027, March 6, 2028, May 20, 2028, August 20, 2028, November 20, 2028, and March 6, 2029; 178 shares vest on May 20, 2029; 93 shares vest on each of August 20, 2029 and November 20, 2029; and 101 shares vest on March 6, 2030. Vesting is contingent upon the reporting person's continued service with the Company through each applicable vesting date.

Read SEC document
May 20, 2026 Filed Jun 22, 2026 20:57 UTC Tax withholdingCommon Stock 762 $62.24 $47,426.88
Disclosure

SEC source: 0001193125-26-277646 · ownership.xml · nonDerivative · entry 1

REEVE GRAHAM D. · CIK 0001519948 · COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,316

F1 · shares: The reporting person surrendered shares to the issuer to satisfy applicable tax withholding obligations upon vesting.

F2 · balance_after: Includes 19,436 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,948 shares will vest on each of August 20, 2026 and November 20, 2026, 1,956 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates.

Read SEC document
May 19, 2026 Filed May 20, 2026 20:39 UTC GrantCommon Stock 2,306 $61.61 $142,072.66
Disclosure

SEC source: 0001193125-26-232731 · ownership.xml · nonDerivative · entry 1

Motsenbocker Anne · CIK 0001904253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,812

F1 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if she is a director of the Company on those dates.

Read SEC document
May 19, 2026 Filed May 20, 2026 20:20 UTC GrantCommon Stock 2,306 $61.61 $142,072.66
Disclosure

SEC source: 0001193125-26-232641 · ownership.xml · nonDerivative · entry 1

Swanson Regg E. · CIK 0001412473 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,492

F1 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.

Read SEC document
May 19, 2026 Filed May 20, 2026 20:14 UTC GrantCommon Stock 2,306 $61.61 $142,072.66
Disclosure

SEC source: 0001193125-26-232596 · ownership.xml · nonDerivative · entry 1

Minan Peter Francis · CIK 0001544647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,431

F1 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.

Read SEC document
May 19, 2026 Filed May 20, 2026 20:12 UTC GrantCommon Stock 2,306 $61.61 $142,072.66
Disclosure

SEC source: 0001193125-26-232590 · ownership.xml · nonDerivative · entry 1

Harris Bernard A Jr · CIK 0001337906 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,914

F1 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.

Read SEC document
May 19, 2026 Filed May 20, 2026 20:08 UTC GrantCommon Stock 2,306 $61.61 $142,072.66
Disclosure

SEC source: 0001193125-26-232573 · ownership.xml · nonDerivative · entry 1

Gilmartin Kathleen A · CIK 0001741732 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,092

F1 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if she is a director of the Company on those dates.

Read SEC document
May 19, 2026 Filed May 28, 2026 20:22 UTC Amendment GrantCommon Stock 2,306 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-245298 · ownership.xml · nonDerivative · entry 1

Swanson Regg E. · CIK 0001412473 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,492

F1 · price: 5/19/2026 - Transaction price should have been reported as $0.00, not $61.61.

F2 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.

Read SEC document
May 19, 2026 Filed May 28, 2026 20:19 UTC Amendment GrantCommon Stock 2,306 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-245285 · ownership.xml · nonDerivative · entry 1

Motsenbocker Anne · CIK 0001904253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,812

F1 · price: 5/19/2026 - Transaction price should have been reported as $0.00, not $61.61.

F2 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if she is a director of the Company on those dates.

Read SEC document
May 19, 2026 Filed May 28, 2026 20:14 UTC Amendment GrantCommon Stock 2,306 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-245256 · ownership.xml · nonDerivative · entry 1

Minan Peter Francis · CIK 0001544647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,431

F1 · price: 5/19/2026 - Transaction price should have been reported as $0.00, not $61.61.

F2 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.

Read SEC document
May 19, 2026 Filed May 28, 2026 20:11 UTC Amendment GrantCommon Stock 2,306 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-245238 · ownership.xml · nonDerivative · entry 1

Harris Bernard A Jr · CIK 0001337906 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,914

F1 · price: 5/19/2026 - Transaction price should have been reported as $0.00, not $61.61.

F2 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.

Read SEC document
May 19, 2026 Filed May 28, 2026 20:08 UTC Amendment GrantCommon Stock 2,306 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-245224 · ownership.xml · nonDerivative · entry 1

Gilmartin Kathleen A · CIK 0001741732 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,092

F1 · price: 5/19/2026 - Transaction price should have been reported as $0.00, not $61.61.

F2 · balance_after: Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if she is a director of the Company on those dates.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 20:41 UTC SaleCommon Stock 662 $78.86 $52,205.32
Disclosure

SEC source: 0001193125-26-104315 · ownership.xml · nonDerivative · entry 1

REEVE GRAHAM D. · CIK 0001519948 · COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,078

F1 · price: The price reported ($78.86) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $78.82 to $79.82 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F2 · balance_after: Includes 21,384 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,948 shares will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 1,956 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates.

Read SEC document
March 09, 2026 Filed Mar 10, 2026 21:21 UTC
HENDRICKSON CAREY PChief Financial Officer
Disposition to issuerCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-100453 · ownership.xml · nonDerivative · entry 1

HENDRICKSON CAREY P · CIK 0001482760 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,808

F1 · balance_after: Includes 11,070 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,246 shares will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 1,252 shares will vest on March 6, 2027, 1,012 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares will vest on March 6, 2028, 506 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 510 shares will vest on March 6, 2029 if he remains employed by the Company on those dates.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 20:38 UTC SaleCommon Stock 1 $78.52 $78.52
Disclosure

SEC source: 0001193125-26-102296 · ownership.xml · nonDerivative · entry 2

REEVE GRAHAM D. · CIK 0001519948 · COO

10b5-1 filing: No plan indicated

Ownership: Indirect · Reeve Trust

Disclosed balance after: 0

Read SEC document
March 06, 2026 Filed Mar 9, 2026 20:28 UTC
Binstein RichardEVP Gen'l Counsel & Secretary
SaleCommon Stock 3,000 $81.64 $244,920.00
Disclosure

SEC source: 0001193125-26-098618 · ownership.xml · nonDerivative · entry 1

Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,867

F1 · balance_after: Includes 21,070 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as to 1,870 shares will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 1,876 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates.

Read SEC document
March 06, 2026 Filed Mar 11, 2026 20:38 UTC SaleCommon Stock 1,807 $82.25 $148,625.75
Disclosure

SEC source: 0001193125-26-102296 · ownership.xml · nonDerivative · entry 1

REEVE GRAHAM D. · CIK 0001519948 · COO

10b5-1 filing: No plan indicated

Ownership: Indirect · Reeve Trust

Disclosed balance after: 1

Read SEC document
February 23, 2026 Filed Feb 26, 2026 01:46 UTC
READING CHRISTOPHER JDirector · Chairman of the Board and CEO
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-072717 · ownership.xml · nonDerivative · entry 1

READING CHRISTOPHER J · CIK 0001270356 · Director · Chairman of the Board and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,088

F1 · shares: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. The restrictions lapse in 15 equal quarterly installments of 1,562 shares beginning on May 20, 2026 and on each of March 6, May 20, August 20, and November 20 of each of the years 2026, 2027, 2028, and 2029 and 1,570 shares vesting on March 6, 2030

F2 · balance_after: Includes 54,946 shares, inclusive of those mentioned in Footnote 1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 4,152 shares vest on March 6, 2026; 4,464 shares vest on each of May 20, 2026, August 20, 2026, November 20, 2026 and March 6, 2027; 3,839 shares vest on each of May 20, 2027, August 20, 2027, and November 20, 2027; 3,847 shares vest on March 6, 2028; 2,827 shares vest on each of May 20, 2028, August 20, 2028, and November 20, 2028; 2,837 shares vest on March 6, 2029; 1,562 shares vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 1,570 shares vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each applicable vesting date.

Read SEC document
February 23, 2026 Filed Feb 26, 2026 01:42 UTC GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-072703 · ownership.xml · nonDerivative · entry 1

REEVE GRAHAM D. · CIK 0001519948 · COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,740

F1 · shares: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 quarterly installments of 624 shares vesting beginning on May 20, 2026 and on each of March 6, May 20, August 20, and November 20 of each year 2026, 2027, 2028, and 2029 and 640 shares vesting on March 6, 2030, if he still employed by the Company as of those dates.

F2 · balance_after: Includes 23,348 shares, inclusive of those mentioned in Footnote 1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,964 shares will vest on March 6, 2026; 1,948 shares will vest on each of May 20, 2026, August 20, 2026, November 20, 2026; 1,956 shares will vest on March 6, 2027; 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027; 1,640 shares will vest on March 6, 2028; 1,130 shares will vest on each of May 20, 2028, August 20, 2028, November 20, 2028; 1,134 shares will vest on March 6, 2029; 624 shares will vest on each of May 20, 2029, August 20, 2029, November 20, 2029 and the remaining 640 shares will vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each applicable vesting date.

Read SEC document
February 23, 2026 Filed Feb 26, 2026 01:21 UTC
Binstein RichardEVP Gen'l Counsel & Secretary
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-072647 · ownership.xml · nonDerivative · entry 1

Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,867

F1 · shares: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 quarterly installments of 624 shares vesting beginning on May 20, 2026 and on each of March 6, May 20, August 20, and November 20 of each year 2026, 2027, 2028 and 2029 and 640 shares vesting on March 6, 2030, if he still employed by the Company as of those dates.

F2 · balance_after: Includes 22,624 (including the awards mentioned in note 1) which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as to 1,554 shares will vest on March 6, 2026, 1,870 shares will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 1,876 shares on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027 and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028 and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2028 and November 20, 2029 and the final 640 shares will vest on March 6, 2030.

Read SEC document
February 23, 2026 Filed Feb 26, 2026 01:45 UTC
Williams Eric JosephPresident and COO
GrantCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-072715 · ownership.xml · nonDerivative · entry 1

Williams Eric Joseph · CIK 0001871391 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,331

F1 · shares: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. The restrictions lapse in fifteen (15) equal quarterly installments of 936 shares vesting on each of May 20, August 20, November 20, and March 6 of each of the years 2026, 2027, 2028, and 2029. The final 960 shares vesting on March 6, 2030. Vesting is subject to his continued employment with the Company through each of the applicable vesting dates.

F2 · balance_after: Includes 31,322 shares, inclusive of those mentioned in Footnote 1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,896 shares vest on March 6, 2026; 2,512 shares vest on May 20, 2026, August 20, 2026, November 20, 2026; 2,520 shares vest on March 6, 2027; 2,200 shares vest on May 20, 2027, August 20, 2027, and November 20, 2027; 2,204 shares vest on March 6, 2028; 1,694 shares vest on May 20, 2028, August 20, 2028, and November 20, 2028; 1,716 shares will vest on March 6, 2029; 936 shares vest on May 20, 2029, August 20, 2029 and November 20, 2029; and 960 shares will vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each of the applicable vesting dates.

Read SEC document
February 23, 2026 Filed Feb 26, 2026 01:15 UTC
HENDRICKSON CAREY PChief Financial Officer
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-072630 · ownership.xml · nonDerivative · entry 1

HENDRICKSON CAREY P · CIK 0001482760 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,808

F1 · shares: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. The restrictions lapse in fifteen (15) equal quarterly installments of 624 shares each, vesting on May 20, August 20, and November 20 of 2026, and March 6, May 20, August 20, and November 20 in each of the years 2027, 2028, and 2029; and 640 shares which will vest on March 6, 2030.

F2 · balance_after: Includes 22,796 shares, inclusive of those mentioned in Footnote 1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,726 shares will vest on March 6, 2026; 1,870 shares will vest on each of May 20, 2026, August 20, 2026, November 20, 2026; 1,876 shares will vest on March 6, 2027; 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027; 1,640 shares will vest on March 6, 2028; 1,130 shares will vest on each of May 20, 2028, August 20, 2028, November 20, 2028; 1,134 shares will vest on March 6, 2029; 624 shares will vest on each of May 20, 2029, August 20, 2029, November 20, 2029 and the remaining 640 shares will vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each applicable vesting date.

Read SEC document
November 24, 2025 Filed Nov 25, 2025 21:08 UTC SaleCommon Stock 743 $71.01 $52,760.43
Disclosure

SEC source: 0001193125-25-297192 · ownership.xml · nonDerivative · entry 1

REEVE GRAHAM D. · CIK 0001519948 · COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,740

F1 · price: The price reported $71.01 is the weighted average price. The shares were sold in multiple transactions at prices ranging from $71.01 to $71.31 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F2 · balance_after: Includes 13,348 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,964 shares on March 6, 2026, 1,324 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,332 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates.

Read SEC document
November 20, 2025 Filed Nov 24, 2025 21:09 UTC PurchaseCommon Stock 4,000 $69.00 $276,000.00
Disclosure

SEC source: 0001193125-25-293697 · ownership.xml · nonDerivative · entry 1

Gilmartin Kathleen A · CIK 0001741732 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,786

F1 · balance_after: Includes 471 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. These shares will fully vest on March 6, 2026 if she remains as a member of the Board of Directors of the Company on that date.

Read SEC document
September 11, 2025 Filed Sep 11, 2025 20:51 UTC
HAM NANCYDirector
SaleCommon Stock 600 $81.71 $49,026.00
Disclosure

SEC source: 0000950170-25-114258 · ownership.xml · nonDerivative · entry 1

HAM NANCY · CIK 0001124500 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,994

F1 · balance_after: Includes 941 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates.

Read SEC document
September 05, 2025 Filed Sep 8, 2025 20:15 UTC
Williams Eric JosephPresident and COO
SaleCommon Stock 1,000 $85.25 $85,250.00
Disclosure

SEC source: 0000950170-25-113554 · ownership.xml · nonDerivative · entry 1

Williams Eric Joseph · CIK 0001871391 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,331

F1 · balance_after: Includes 18,210 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,888 shares on November 20, 2025, 1,896 shares on March 6, 2026,1,576 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,584 shares on March 6, 2027, 1,264 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,268 shares on March 6, 2028, 758 shares on each of May 20, 2028, August 20, 2028, November 20, 2028, and 780 shares on March 6, 2029, if he is an employee of the Company on those dates.

Read SEC document
September 04, 2025 Filed Sep 5, 2025 20:15 UTC
READING CHRISTOPHER JDirector · Chairman of the Board and CEO
SaleCommon Stock 2,000 $83.53 $167,060.00
Disclosure

SEC source: 0000950170-25-113254 · ownership.xml · nonDerivative · entry 1

READING CHRISTOPHER J · CIK 0001270356 · Director · Chairman of the Board and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,088

F1 · balance_after: Includes 34,098 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 4,152 shares on each of November 20, 2025 and March 6, 2026, 2,902 shares on each of May 20, 2026, August 20, 2026, November 20, 2026, and March 6, 2027, 2,277 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 2,285 shares on March 6, 2028,1,265 shares on each of May 20, 2028, August 20, 2028, and November 20, 2028, and 1,275 shares on March 6, 2029, if he is an employee of the Company on those dates.

Read SEC document
August 25, 2025 Filed Aug 25, 2025 21:30 UTC
HENDRICKSON CAREY PChief Financial Officer
SaleCommon Stock 698 $86.11 $60,104.78
Disclosure

SEC source: 0000950170-25-111251 · ownership.xml · nonDerivative · entry 1

HENDRICKSON CAREY P · CIK 0001482760 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,808

F1 · balance_after: Includes 14,510 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,714 shares on November 20, 2025, 1,726 shares on March 6, 2026, 1,246 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,252 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates.

Read SEC document
August 21, 2025 Filed Aug 21, 2025 23:54 UTC SaleCommon Stock 763 $84.97 $64,832.11
Disclosure

SEC source: 0000950170-25-110761 · ownership.xml · nonDerivative · entry 1

REEVE GRAHAM D. · CIK 0001519948 · COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,483

F1 · price: The price reported $84.97 is the weighted average price. The shares were sold in multiple transactions at prices ranging from $84.90 to $85.02 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F2 · balance_after: Includes 15,296 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,948 shares on November 20, 2025. 1,964 shares on March 6, 2026, 1,324 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,332 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates.

Read SEC document
August 19, 2025 Filed Aug 19, 2025 21:30 UTC
Binstein RichardEVP Gen'l Counsel & Secretary
Disposition to issuerCommon Stock 2,000 $84.79 $169,580.00
Disclosure

SEC source: 0000950170-25-110193 · ownership.xml · nonDerivative · entry 1

Binstein Richard · CIK 0001919840 · EVP Gen'l Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,867

F1 · balance_after: Includes 15,726 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,551 shares on each of August 20, 2025, and November 20, 2025, 1,554 shares on March 6, 2026, 1,246 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026,1,252 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 01:00 UTC SaleCommon Stock 1,792 $86.57 $155,133.44
Disclosure

SEC source: 0000950170-25-107551 · ownership.xml · nonDerivative · entry 1

REEVE GRAHAM D. · CIK 0001519948 · COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,246

F1 · balance_after: Includes 17,244 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,948 shares on each of August 20, 2025, and November 20, 2025, 1,964 shares on March 6, 2026, 1,324 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,332 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates.

Read SEC document
June 12, 2025 Filed Jun 13, 2025 20:30 UTC
HAM NANCYDirector
SaleCommon Stock 400 $78.01 $31,204.00
Disclosure

SEC source: 0000950170-25-086255 · ownership.xml · nonDerivative · entry 1

HAM NANCY · CIK 0001124500 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,594

F1 · price: The price reported is weighted average price ($78.01). The shares were sold in multiple transactions at prices ranging from $77.99 to $78.03 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F2 · balance_after: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates.

Read SEC document
May 21, 2025 Filed May 22, 2025 20:30 UTC SaleCommon Stock 530 $78.08 $41,382.40
Disclosure

SEC source: 0000950170-25-076382 · ownership.xml · nonDerivative · entry 1

REEVE GRAHAM D. · CIK 0001519948 · COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,244

F1 · price: The price reported is the weighted average price ($78.08) . The shares were sold in multiple transactions at prices ranging from $77.83 to $78.35 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F2 · balance_after: Includes 17,244 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,948 shares on each of August 20, 2025, and November 20, 2025, 1,964 shares on March 6, 2026, 1,324 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,332 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates.

Read SEC document
May 21, 2025 Filed May 22, 2025 20:30 UTC
Williams Eric JosephPresident and COO
SaleCommon Stock 633 $78.09 $49,430.97
Disclosure

SEC source: 0000950170-25-076378 · ownership.xml · nonDerivative · entry 1

Williams Eric Joseph · CIK 0001871391 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,331

F1 · price: The price reported $78.09 is the weighted average price. The shares were sold in multiple transactions at prices ranging from $77.83 to $78.35 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F2 · balance_after: Includes 20,382 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 2,172 shares on each of August 20, 2025, 1,888 shares on November 20, 2025, 1,896 shares on March 6, 2026, 1,576 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,584 shares on March 6, 2027, 1,264 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,268 shares on March 6, 2028, 758 shares of each on May 20, 2028, August 20, 2028, November 20, 2028, and 780 shares on March 6, 2029, if he is an employee of the Company on those dates.

Read SEC document
May 20, 2025 Filed May 21, 2025 20:15 UTC GrantCommon Stock 1,882 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-075788 · ownership.xml · nonDerivative · entry 1

Harris Bernard A Jr · CIK 0001337906 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,608

F1 · shares: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if he is a director of the Company on those dates.

F1 · balance_after: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if he is a director of the Company on those dates.

Read SEC document
May 20, 2025 Filed May 21, 2025 20:15 UTC GrantCommon Stock 1,882 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-075784 · ownership.xml · nonDerivative · entry 1

Trier Clayton · CIK 0001319561 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,306

F1 · shares: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if he is a director of the Company on those dates.

F1 · balance_after: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if he is a director of the Company on those dates.

Read SEC document
May 20, 2025 Filed May 21, 2025 20:15 UTC GrantCommon Stock 1,882 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-075786 · ownership.xml · nonDerivative · entry 1

Swanson Regg E. · CIK 0001412473 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,186

F1 · shares: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if he is a director of the Company on those dates.

F1 · balance_after: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if he is a director of the Company on those dates.

Read SEC document
May 20, 2025 Filed May 21, 2025 20:15 UTC
HAM NANCYDirector
GrantCommon Stock 1,882 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-075782 · ownership.xml · nonDerivative · entry 1

HAM NANCY · CIK 0001124500 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,994

F1 · shares: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates.

F1 · balance_after: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates.

Read SEC document
May 20, 2025 Filed May 21, 2025 20:15 UTC GrantCommon Stock 1,882 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-075781 · ownership.xml · nonDerivative · entry 1

Motsenbocker Anne · CIK 0001904253 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,506

F1 · shares: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates.

F1 · balance_after: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates.

Read SEC document
May 20, 2025 Filed May 21, 2025 20:15 UTC GrantCommon Stock 1,882 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-075778 · ownership.xml · nonDerivative · entry 1

Gilmartin Kathleen A · CIK 0001741732 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,786

F1 · shares: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates.

F1 · balance_after: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.